{"success":true,"data":{"pressRelease":{"id":"119518","rtpr_id":"nACSbdK0Sa","ticker":"PRCT","exchange":"NASDAQ","all_tickers":["PRCT"],"title":"PRCT ALERT: Securities Fraud Class Action Launched Against PROCEPT BioRobotics Corporation - September 22, 2026 Deadline","author":"ACCESSWIRE","published_at":"2026-08-14T13:57:00.539Z","article_body":"NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / August\n14, 2026 / Levi & Korsinsky, LLP announces that a securities class action\nlawsuit has been filed on behalf of investors who purchased or otherwise\nacquired PROCEPT BioRobotics Corporation (NASDAQ:PRCT) securities.\n\nIf you suffered a loss on your PROCEPT BioRobotics Corporation investment and\nwould like to explore a potential recovery under the federal securities laws,\nLearn about PROCEPT BioRobotics Corporation Class Action\n(https://pr.report/p3ly) or contact Joseph E. Levi, Esq. via email at\njlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of\nexperienced shareholder advocates.\n\nTHE LAWSUIT: A class action securities lawsuit was filed against PROCEPT\nBioRobotics Corporation that seeks to recover losses of shareholders who were\nadversely affected by alleged securities fraud between February 28, 2024 and\nFebruary 25, 2026.\n\nCASE DETAILS: The filed complaint alleges that defendants made false\nstatements and/or concealed that: (a) during the class period, Procept had\nutilized an extensive discount program designed to incentivize its customers\nto place bulk orders in excess of procedure demand; (b) Procept's undisclosed\ndiscount program had artificially and unsustainably inflated the Company's\nreported U.S. handpiece unit sales and revenues by pulling forward sales at\nthe expense of future periods; (c) Procept's undisclosed discount program had\ncaused customer handpiece orders to materially exceed underlying procedure\ndemand throughout the class period and that this differential had materially\ngrown over time; (d) Procept's consistent surplus of U.S. handpiece unit sales\nrelative to performed procedures had created a glut of field inventory and\noverstocking amongst Procept's customer base, amounting to more than 10,000\nexcess units by the end of the Class Period; (e) as a result of (a)-(d) above,\ndefendants' representations during the class period regarding Procept's\nhandpiece unit sales and the utilization of Procept's field Systems were\nmaterially overstated; (f) as a result of (a)-(e) above, Procept was acutely\nexposed to material undisclosed risks of significant operational and financial\nharm; and (g) as a result of (a)-(f) above, Procept was unable to achieve its\nstated 2025 handpiece sales and revenue guidance and such guidance lacked a\nreasonably achievable factual basis.\n\nWHAT'S NEXT? If you purchased PROCEPT BioRobotics Corporation stock during the\nrelevant time frame - even if you still hold your shares, learn about your\nrights to seek a recovery (https://pr.report/p3lz). There is no cost or\nobligation to participate.\n\nWHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has\nestablished itself as a nationally-recognized securities litigation firm that\nhas secured hundreds of millions of dollars for aggrieved shareholders and\nbuilt a track record of winning high-stakes cases. The firm has extensive\nexpertise representing investors in complex securities litigation and a team\nof over 70 employees to serve our clients. For seven years in a row, Levi &\nKorsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as\none of the top securities litigation firms in the United States. Attorney\nAdvertising. Prior results do not guarantee similar outcomes.\n\nCONTACT:\nLevi & Korsinsky, LLP\nJoseph E. Levi, Esq.\nEd Korsinsky, Esq.\n33 Whitehall Street, 27th Floor\nNew York, NY 10004\njlevi@levikorsinsky.com\nTel: (212)363-7500\nFax: (212) 363-7171\n\nSOURCE: Levi & Korsinsky, LLP\nView the original press release\n(https://www.accessnewswire.com/newsroom/en/business-and-professional-services/prct-alert-securities-fraud-class-action-launched-against-procep-1207332)\non ACCESS Newswire\n\n\nCopyright 2026 ACCESS Newswire. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nACSbdK0Sa","title":"PRCT ALERT: Securities Fraud Class Action Launched Against PROCEPT BioRobotics Corporation - September 22, 2026 Deadline","author":"ACCESSWIRE","ticker":"PRCT","created":"2026-08-14T13:57:00.539Z","tickers":["PRCT"],"exchange":"NASDAQ","article_body":"NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / August\n14, 2026 / Levi & Korsinsky, LLP announces that a securities class action\nlawsuit has been filed on behalf of investors who purchased or otherwise\nacquired PROCEPT BioRobotics Corporation (NASDAQ:PRCT) securities.\n\nIf you suffered a loss on your PROCEPT BioRobotics Corporation investment and\nwould like to explore a potential recovery under the federal securities laws,\nLearn about PROCEPT BioRobotics Corporation Class Action\n(https://pr.report/p3ly) or contact Joseph E. Levi, Esq. via email at\njlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of\nexperienced shareholder advocates.\n\nTHE LAWSUIT: A class action securities lawsuit was filed against PROCEPT\nBioRobotics Corporation that seeks to recover losses of shareholders who were\nadversely affected by alleged securities fraud between February 28, 2024 and\nFebruary 25, 2026.\n\nCASE DETAILS: The filed complaint alleges that defendants made false\nstatements and/or concealed that: (a) during the class period, Procept had\nutilized an extensive discount program designed to incentivize its customers\nto place bulk orders in excess of procedure demand; (b) Procept's undisclosed\ndiscount program had artificially and unsustainably inflated the Company's\nreported U.S. handpiece unit sales and revenues by pulling forward sales at\nthe expense of future periods; (c) Procept's undisclosed discount program had\ncaused customer handpiece orders to materially exceed underlying procedure\ndemand throughout the class period and that this differential had materially\ngrown over time; (d) Procept's consistent surplus of U.S. handpiece unit sales\nrelative to performed procedures had created a glut of field inventory and\noverstocking amongst Procept's customer base, amounting to more than 10,000\nexcess units by the end of the Class Period; (e) as a result of (a)-(d) above,\ndefendants' representations during the class period regarding Procept's\nhandpiece unit sales and the utilization of Procept's field Systems were\nmaterially overstated; (f) as a result of (a)-(e) above, Procept was acutely\nexposed to material undisclosed risks of significant operational and financial\nharm; and (g) as a result of (a)-(f) above, Procept was unable to achieve its\nstated 2025 handpiece sales and revenue guidance and such guidance lacked a\nreasonably achievable factual basis.\n\nWHAT'S NEXT? If you purchased PROCEPT BioRobotics Corporation stock during the\nrelevant time frame - even if you still hold your shares, learn about your\nrights to seek a recovery (https://pr.report/p3lz). There is no cost or\nobligation to participate.\n\nWHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has\nestablished itself as a nationally-recognized securities litigation firm that\nhas secured hundreds of millions of dollars for aggrieved shareholders and\nbuilt a track record of winning high-stakes cases. The firm has extensive\nexpertise representing investors in complex securities litigation and a team\nof over 70 employees to serve our clients. For seven years in a row, Levi &\nKorsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as\none of the top securities litigation firms in the United States. Attorney\nAdvertising. Prior results do not guarantee similar outcomes.\n\nCONTACT:\nLevi & Korsinsky, LLP\nJoseph E. Levi, Esq.\nEd Korsinsky, Esq.\n33 Whitehall Street, 27th Floor\nNew York, NY 10004\njlevi@levikorsinsky.com\nTel: (212)363-7500\nFax: (212) 363-7171\n\nSOURCE: Levi & Korsinsky, LLP\nView the original press release\n(https://www.accessnewswire.com/newsroom/en/business-and-professional-services/prct-alert-securities-fraud-class-action-launched-against-procep-1207332)\non ACCESS Newswire\n\n\nCopyright 2026 ACCESS Newswire. All Rights Reserved."},"type":"article","timestamp":"2026-08-14T13:57:00.58907161Z","server_sent_at_ms":1786715820589},"received_at":"2026-08-14T13:57:00.639Z","source_url":"https://www.accessnewswire.com/newsroom/en/business-and-professional-services/prct-alert-securities-fraud-class-action-launched-against-procep-1207332"},"analysis":{"id":"108503","press_release_id":"119518","analysis_json":{"industry":{"label":"Health Care Equipment","sector":"Health Care"},"redFlags":[],"eventType":"legal_litigation","narrative":"Levi & Korsinsky LLP announced that a class action lawsuit has been filed against PROCEPT BioRobotics on behalf of investors who purchased securities between February 2024 and February 2026.\n\nThe complaint alleges the company used undisclosed discount programs to incentivize bulk orders, creating a glut of inventory and artificially inflating revenue.\n\nThe firm is encouraging affected investors to contact them regarding their rights before the September 22, 2026 lead plaintiff deadline.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation -- suppress."},"quotedText":"There is no cost or obligation to participate","namedEntities":{"people":[{"name":"Joseph E. Levi, Esq."},{"name":"Ed Korsinsky, Esq."}],"products":[],"companies":[{"name":"Levi & Korsinsky, LLP","relationship":"plaintiff law firm"},{"name":"PROCEPT BioRobotics Corporation","ticker":"PRCT","relationship":"defendant"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm shareholder solicitation issued by Levi & Korsinsky LLP. No new disclosure from the issuer; no certified class, no settlement. Boilerplate lead-plaintiff-deadline reminder."},"tickerRelevance":{"others":[],"primary":"PRCT"},"globalImportance":10,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Levi & Korsinsky LLP announced that a class action lawsuit has been filed against PROCEPT BioRobotics on behalf of investors who purchased securities between February 2024 and February 2026.\n\nThe complaint alleges the company used undisclosed discount programs to incentivize bulk orders, creating a glut of inventory and artificially inflating revenue.\n\nThe firm is encouraging affected investors to contact them regarding their rights before the September 22, 2026 lead plaintiff deadline.","key_figures":null,"named_entities":{"people":[{"name":"Joseph E. Levi, Esq."},{"name":"Ed Korsinsky, Esq."}],"products":[],"companies":[{"name":"Levi & Korsinsky, LLP","relationship":"plaintiff law firm"},{"name":"PROCEPT BioRobotics Corporation","ticker":"PRCT","relationship":"defendant"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-08-14T15:13:01.785Z","global_importance":10,"audience_relevance":10,"importance_components":{"tickerTier":"small-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"durationMs":null,"modelName":"glm-4.7"}}